The DOI matches its Crossref record; 50 of the 50 references it cites were found in a registry or an index.
MAIT cells are chronically activated in patients with autoimmune liver disease and promote profibrogenic hepatic stellate cell activation
Open accessAbstract
Autoimmune liver diseases (AILDs) are chronic liver pathologies characterized by fibrosis and cirrhosis due to immune-mediated liver damage. In this study, we addressed the question whether mucosal-associated invariant T (MAIT) cells, innate-like T cells, are functionally altered in patients with AILD and whether MAIT cells can promote liver fibrosis through activation of hepatic stellate cells (HSCs). We analyzed the phenotype and function of MAIT cells from AILD patients and healthy controls by multicolor flow cytometry and investigated the interaction between human MAIT cells and primary human hepatic stellate cells (hHSCs). We show that MAIT cells are significantly decreased in peripheral blood and liver tissue of patients with AILD. Notably, MAIT cell frequency tended to decrease with increasing fibrosis stage. MAIT cells from AILD patients showed signs of exhaustion, such as impaired interferon-γ (IFN-γ) production and high ex vivo expression of the activation and exhaustion markers CD38, HLA-DR, and CTLA-4. Mechanistically, this exhausted state could be induced by repetitive stimulation of MAIT cells with the cytokines interleukin (IL)-12 and IL-18, leading to decreased IFN-γ and increased exhaustion marker expression. Of note, repetitive stimulation with IL-12 further resulted in expression of the profibrogenic cytokine IL-17A by otherwise exhausted MAIT cells. Accordingly, MAIT cells from both healthy controls and AILD patients were able to induce an activated, proinflammatory and profibrogenic phenotype in hHSCs in vitro that was partly mediated by IL-17. CONCLUSION: Our data provide evidence that MAIT cells in AILD patients have evolved towards an exhausted, profibrogenic phenotype and can contribute to the development of HSC-mediated liver fibrosis. These findings reveal a cellular and molecular pathway for fibrosis development in AILD that could be exploited for antifibrotic therapy. (Hepatology 2018;68:172-186).
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“The crucial role 446 of MAIT cells as liver sentinels against bacteria is suggested by the effect of their 447 dysfunction in alcoholic liver disease, which increases greatly the susceptibility of these 448 patients to liver infections(90, 91).”
From The liver as a central "hub" of the immune system: pathophysiological implications (2025) · cites this paper as [91]
Experimental — accuracy not yet measuredIn the citing paper
“Although the role of MAIT cells in the liver is evolving, experimental evidence clearly supports their profibrogenic activity in the chronically injured liver.99,100”
From An integrated view of anti-inflammatory and antifibrotic targets for the treatment of NASH (2023) · cites this paper as [100]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Ivanov, I. I., McKenzie, B. S., Zhou, L., Tadokoro, C. E., Lepelley, A., Lafaille, J. J., Cua, D. J., & Littman, D. R. (2006) · Cell · doi:10.1016/j.cell.2006.07.035 · Cited by 5,145
Korn, T., Bettelli, E., Oukka, M., & Kuchroo, V. K. (2009) · Annual Review of Immunology · doi:10.1146/annurev.immunol.021908.132710 · Cited by 4,873
Wherry, E. J. (2011) · Nature Immunology · doi:10.1038/ni.2035 · Cited by 4,062 · cited 1×
“The severe decline of MAIT cells observed in both peripheral blood and liver tissue of AILD patients probably results from chronic activation and cellular exhaustion, which is commonly characterized by a hierarchical loss of effector function, followed by cell death.((30)) T cell exhaustion arises from chronic exposur…”
BackgroundInterleukin-12 and the regulation of innate resistance and adaptive immunity
Trinchieri, G. (2003) · Nature reviews. Immunology · doi:10.1038/nri1001 · Cited by 4,007
Castéra, L., Vergniol, J., Foucher, J., Bail, B. L., Chanteloup, E., Haaser, M., Darriet, M., Couzigou, P., & de Lédinghen, V. (2005) · Gastroenterology · doi:10.1053/j.gastro.2004.11.018 · Cited by 2,480
Viral Immune Evasion Due to Persistence of Activated T Cells Without Effector Function
Zajac, A. J., Blattman, J. N., Murali-Krishna, K., Sourdive, D. J. D., Suresh, M., Altman, J. D., & Ahmed, R. (1998) · The Journal of Experimental Medicine · doi:10.1084/jem.188.12.2205 · Cited by 1,978
Ahmadzadeh, M., Johnson, L. A., Heemskerk, B., Wunderlich, J. R., Dudley, M. E., White, D. E., & Rosenberg, S. A. (2009) · Blood · doi:10.1182/blood-2008-12-195792 · Cited by 1,766
MR1 presents microbial vitamin B metabolites to MAIT cells
Kjer-Nielsen, L., Patel, O., Corbett, A. J., Le Nours, J., Meehan, B., Liu, L., Bhati, M., Chen, Z., Kostenko, L., Reantragoon, R., et al. (2012) · Nature · doi:10.1038/nature11605 · Cited by 1,351
The IL-23/IL-17 axis in inflammation
Iwakura, Y. (2006) · Journal of Clinical Investigation · doi:10.1172/jci28508 · Cited by 1,068
Human MAIT cells are xenobiotic-resistant, tissue-targeted, CD161hi IL-17–secreting T cells
Dusséaux, M., Martin, E., Serriari, N., Péguillet, I., Prémel, V., Louis, D., Milder, M., Bourhis, L. L., Soudais, C., Treiner, E., et al. (2010) · Blood · doi:10.1182/blood-2010-08-303339 · Cited by 1,045
Flagged first, then by citations
Cited by
Sorted by citations
Items 101–183 of 183
The TL1A-DR3 Axis Selectively Drives Effector Functions in Human MAIT Cells
Sattler, A., Thiel, L. G., Ruhm, A. H., Souidi, N., Seifert, M., Herberth, G., & Kotsch, K. (2019) · The Journal of Immunology · doi:10.4049/jimmunol.1900465 · Cited by 13
Harnessing the Power of Mucosal-Associated Invariant T (MAIT) Cells in Cancer Cell Therapy
Sugimoto, C., Fujita, H., & Wakao, H. (2022) · Biomedicines · doi:10.3390/biomedicines10123160 · Cited by 12
Böttcher, K., Longato, L., Marrone, G., Mazza, G., Ghemtio, L., Hall, A. R., Luong, T. V., Caruso, S., Viollet, B., Zucman‐Rossi, J., et al. (2021) · American Journal of Physiology-Gastrointestinal and Liver Physiology · doi:10.1152/ajpgi.00262.2020 · Cited by 13
Self-citationMucosal immunity in primary sclerosing cholangitis: from the bowel to bile ducts and back again
Liaskou, E., Quraishi, M. N., & Trivedi, P. J. (2022) · Current Opinion in Gastroenterology · doi:10.1097/mog.0000000000000809 · Cited by 12
Yüksel, M., Nazmi, F., Wardat, D., Akgül, S. U., Polat, E., Akyıldız, M., & Arıkan, Ç. (2023) · Frontiers in Immunology · doi:10.3389/fimmu.2022.1053216 · Cited by 11
Du, Y., Khera, T., Strunz, B., Deterding, K., Tödt, D., Woller, N., Engelskircher, S. A., Hardtke, S., Port, K., Ponzetta, A., et al. (2021) · European Journal of Immunology · doi:10.1002/eji.202149457 · Cited by 11
Sun, R., Xiang, Z., & Wu, B. (2022) · Portal hypertension & cirrhosis · doi:10.1002/poh2.11 · Cited by 12
MAIT cells and their implication in human oral diseases
Jiang, Q. L., Wang, F., Yang, J., & Zhou, G. (2022) · Inflammation Research · doi:10.1007/s00011-022-01600-3 · Cited by 14
Kishi, H., Usui, I., Jojima, T., Fujisaka, S., Wakamatsu, S., Mizunuma-Inoue, Y., Niitani, T., Sakurai, S., Iijima, T., Tomaru, T., et al. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms232315309 · Cited by 12
Rathod, S. (2022) · International review of cytology · doi:10.1016/bs.ircmb.2022.04.013 · Cited by 10
Khlaiphuengsin, A., Chuaypen, N., Sodsai, P., Reantragoon, R., Han, W. M., Avihingsanon, A., & Tangkijvanich, P. (2020) · PLoS ONE · doi:10.1371/journal.pone.0244112 · Cited by 10
Liu, N., Zhong, L., Ni, G., Jiao, L., Xie, L., Li, T., Dan, H., & Chen, Q. (2021) · OncoTargets and Therapy · doi:10.2147/ott.s309576 · Cited by 9
Treiner, E. (2023) · Frontiers in Immunology · doi:10.3389/fimmu.2023.1160943 · Cited by 9
Stonebraker, J. R., Pace, R. G., Gallins, P. J., Dang, H., Aksit, M. A., Faino, A., Gordon, W. W., MacParland, S. A., Bamshad, M. J., Gibson, R. L., et al. (2024) · Hepatology · doi:10.1097/hep.0000000000000863 · Cited by 9
Maekawa, T., Osawa, Y., Okada, Y., Tachi, N., Teramoto, M., Kawamura, T., Horiuchi, T., Kato, S., Kobayashi, A., Kobayashi, S., et al. (2018) · PLoS ONE · doi:10.1371/journal.pone.0207149 · Cited by 9
Role of MAIT cells in metabolic diseases
Toubal, A., & Lehuen, A. (2020) · Molecular Immunology · doi:10.1016/j.molimm.2020.12.014 · Cited by 10
Advances in clinical detection methods and nanomaterials for autoimmune liver diseases
Chen, J., Zhu, Y., Wang, Q., Ding, J., & Chen, X. (2023) · Nano TransMed · doi:10.1016/j.ntm.2023.100003 · Cited by 8
MAIT cell activation in adolescents is impacted by bile acid concentrations and body weight
Mendler, A., Pierzchalski, A., Bauer, M., Röder, S. W., Sattler, A., Standl, M., Borte, M., von Bergen�, M., Rolle-Kampczyk, U. E., & Herberth, G. (2020) · Clinical & Experimental Immunology · doi:10.1111/cei.13423 · Cited by 7
Potential of MAIT cells to modulate asthma
Shimizu, Y., Sugimoto, C., & Wakao, H. (2023) · Allergology International · doi:10.1016/j.alit.2023.07.006 · Cited by 7
Gomes, W. R., Hama, S., Napolitani, G., Tan, A. C., Catto, L. F. B., Donaires, F. S., Santana, B. A., Carvalho, V. S., Martínez, E. Z., Condino‐Neto, A., et al. (2025) · Blood Advances · doi:10.1182/bloodadvances.2025015976 · Cited by 7
Rha, M., Han, J. W., Koh, J., Lee, H. S., Kim, J. H., Cho, K., Kim, S. I., Kim, M. S., Lee, J. G., Park, S., et al. (2021) · Gut · doi:10.1136/gutjnl-2020-322182 · Cited by 7
Xiong, K., Sun, W., Wang, H., Xie, J., Su, B., & Fan, L. (2021) · Cellular Immunology · doi:10.1016/j.cellimm.2021.104381 · Cited by 8
Wang, W., Dai, C., Zhu, P., Wu, M., Zhang, H., Wei, Q., Zhou, T., Tan, X., Jiang, Y., Cheng, X. Y., et al. (2025) · Nature Communications · doi:10.1038/s41467-025-59308-x · Cited by 9
Wang, W. J., Weng, J., Zhang, H., Wu, M., Zhou, T., Jiang, Y., Wu, X., Ye, C., & Weng, X. (2024) · International Immunopharmacology · doi:10.1016/j.intimp.2024.113175 · Cited by 6
CD3+CD4−CD8− T cells: a new potential therapeutic target in treating autoimmune diseases
Li, X., Guo, D., Zou, I. X., Zhao, L., Yang, N., & Liu, Y. (2025) · Frontiers in Immunology · doi:10.3389/fimmu.2025.1683418 · Cited by 6
Microarray‐based transcriptional profiling of a mouse model of autoimmune hepatitis
Liu, Y., Chen, H., Hao, J., Li, Z., Hou, T., & Hao, H. (2020) · FEBS Open Bio · doi:10.1002/2211-5463.12953 · Cited by 6
Akasov, R., & Khaydukov, E. V. (2020) · Frontiers in Immunology · doi:10.3389/fimmu.2020.01896 · Cited by 6
Peritoneal Immunity in Liver Disease
Delo, J., Forton, D. M., Triantafyllou, E., & Singanayagam, A. (2023) · Livers · doi:10.3390/livers3020016 · Cited by 5
Mucosal-Associated Invariant T Cells in the Digestive System: Defender or Destroyer?
Zhang, H., Shen, H., Zhou, L., Xie, L., Kong, D., & Wang, H. (2022) · Cellular and Molecular Gastroenterology and Hepatology · doi:10.1016/j.jcmgh.2022.12.014 · Cited by 6
Lin, X., Wang, Y., & He, Y. (2024) · Journal of Inflammation · doi:10.1186/s12950-024-00376-z · Cited by 6
Jaatinen, K. J., Shah, P. M., Mazhari, R., Hayden, Z., Wargowsky, R. S., Jepson, T., Toma, I., Perkins, J., & McCaffrey, T. A. (2024) · Frontiers in Cardiovascular Medicine · doi:10.3389/fcvm.2024.1385457 · Cited by 4
Regulation of MAIT cells through host-derived antigens
Ito, E., & Yamasaki, S. (2024) · Frontiers in Immunology · doi:10.3389/fimmu.2024.1424987 · Cited by 4
Defenders or defectors: mucosal-associated invariant T cells in autoimmune diseases
Kronenberg, M., & Riffelmacher, T. (2025) · Current Opinion in Immunology · doi:10.1016/j.coi.2025.102542 · Cited by 4
Xia, Q., Lyu, Z., Zhao, Y., Pu, X., Wang, J., Liu, Y., Zhou, Y., Qian, J., Gershwin, M. E., Lian, M., et al. (2025) · Journal of Autoimmunity · doi:10.1016/j.jaut.2025.103442 · Cited by 4
Wei, L., Chen, Z., & Lv, Q. (2023) · Amino Acids · doi:10.1007/s00726-023-03344-8 · Cited by 4
Pyroptotic MAITs link microbial translocation with severity of alcohol-associated liver disease
Zhang, L., Wang, H.-F., Zhai, X., Zhou, C., Yuan, J., Ma, Y.-N., Yao, Z.-T., Huang, S., Li, W.-Z., Jiao, Y., et al. (2023) · Hepatology Communications · doi:10.1097/hc9.0000000000000159 · Cited by 4
Lian, Z., & Li, L. (2020) · Springer eBooks · doi:10.1007/978-3-030-51709-0_2 · Cited by 4
Hackstein, C.-P., & Klenerman, P. (2020) · Cellular and Molecular Gastroenterology and Hepatology · doi:10.1016/j.jcmgh.2020.02.002 · Cited by 4
Primary Biliary Cholangitis Pathogenesis: A Pathophysiology-Based Narrative Review
Papachristou, K., Angelara, M., Manganas, K., & Ανδρουτσάκος, Θ. (2026) · International Journal of Molecular Sciences · doi:10.3390/ijms27031388 · Cited by 3
Figueiredo, A. B., Morais, K. L. P., da Silva, I. T., Maia, L. B. L., Buttura, J. R., Barros, B. D. D. F., Alves, N. S., Pignataro-Oshiro, F., Shimon, S. M. M., Teixeira‐Carvalho, A., et al. (2025) · The Journal of Infectious Diseases · doi:10.1093/infdis/jiaf042 · Cited by 3
MAIT cells predict long-term prognosis in liver failure patients
Cheng, T., Xue, H., Li, H., Liu, Y., Tian, L., Bian, Z., & Chen, F.-S. (2022) · Medicine · doi:10.1097/md.0000000000029809 · Cited by 3
MAIT cells in bacterial infectious diseases: heroes, villains, or both?
Wu, S.-H., Yang, X., Lou, Y., & Xiao, X. (2023) · Clinical & Experimental Immunology · doi:10.1093/cei/uxad102 · Cited by 3
Interplay of autophagy, apoptosis, and senescence in primary biliary cholangitis
Kouroumalis, E., Tsomidis, I., & Voumvouraki, A. (2023) · Exploration of Digestive Diseases · doi:10.37349/edd.2023.00028 · Cited by 3
Phenotype and function of MAIT cells in patients with alveolar echinococcosis
Li, J., Zhao, H., Lv, G., Aimulajiang, K., Li, L., Lin, R., & Aji, T. (2024) · Frontiers in Immunology · doi:10.3389/fimmu.2024.1343567 · Cited by 3
Hetemäki, I., Sarkkinen, J., Wong, H. H., Heikkilä, N., Laakso, S. M., Miettinen, S., Mäyränpää, M. I., Mäkitie, O., Arstila, T. P., & Kekäläinen, E. (2024) · European Journal of Immunology · doi:10.1002/eji.202451189 · Cited by 3
Azad, A. I., Gutiérrez, F., & Gores, G. J. (2025) · Cells · doi:10.3390/cells15010069 · Cited by 2
Ye, X., Song, Y., Zhao, Y., & Zhu, D. (2023) · PubMed Central · doi:10.12122/j.issn.1673-4254.2023.11.07 · Cited by 2
Wu, M., Li, F., Zhou, T., Zhao, J., Jiang, L., Zhang, H., Wang, W., Cheng, X. Y., Wu, X., Xiong, M., et al. (2024) · Molecular Human Reproduction · doi:10.1093/molehr/gaae006 · Cited by 2
Wu, X., Chen, S., Yang, Y., Xu, X., Xiong, X., & Meng, W. (2024) · BMC Oral Health · doi:10.1186/s12903-024-04959-3 · Cited by 2
Mi, Q., Wu, X., Chen, Y., & Meng, W. (2025) · Inflammation Research · doi:10.1007/s00011-024-01990-6 · Cited by 2
Liver damage and immune responses
Hackstein, C.-P. (2025) · Zeitschrift für Gastroenterologie · doi:10.1055/a-2365-3796 · Cited by 2
Strunz, B., Zimmer, C. L., Bister, J., Ivarsson, M. A., & Björkström, N. K. (2019) · Methods in molecular biology · doi:10.1007/978-1-0716-0207-2_5 · Cited by 2
Acute bacterial and viral infections
Juanola, O., Caparrós, E., & Francés, R. (2024) · Elsevier eBooks · doi:10.1016/b978-0-323-95262-0.00011-5 · Cited by 1
Groth, C., Wupper, S., Gnouamozi, G. E., Böttcher, K., & Cerwenka, A. (2024) · Livers · doi:10.3390/livers4040040 · Cited by 3
Self-citationDiverse immunological roles of liver‐resident immune cells in liver diseases
Fan, Z., Li, X., Jiang, P., Teng, D., & Cai, J. (2026) · Precision Medical Sciences · doi:10.1002/prm2.70026 · Cited by 1
Alberola, I. D., Zeo-Sánchez, D. E. D., Garrido‐Rodríguez, V., Gomez, C. L., Rodriguez‐Diaz, C., Andrade, R. J., Lucena, M. I., Paz, M. V., & García‐Fuentes, E. (2026) · Acta Pharmaceutica Sinica B · doi:10.1016/j.apsb.2026.04.014 · Cited by 1
Environmental regulation of mucosal-associated invariant T cells: Adding food for thought
Ryan, E. K., Sinclair, L. V., & Hogan, A. E. (2026) · Science Signaling · doi:10.1126/scisignal.aec6992 · Cited by 1
Immunopathogenesis of Liver Cirrhosis
Guillot, A., & Gao, B. (2020) · Springer eBooks · doi:10.1007/978-3-030-51709-0_35 · Cited by 1
MAIT Cells in Viral Hepatitis and Liver Diseases
Binder, B., Thimme, R., & Hofmann, M. (2021) · Critical Reviews in Immunology · doi:10.1615/critrevimmunol.2022041413 · Cited by 1
Bengtsson, B., Maucourant, C., Sandberg, J. K., Björkström, N. K., & Hagström, H. (2024) · PLoS ONE · doi:10.1371/journal.pone.0294695 · Cited by 1
Biliary strictures in primary sclerosing cholangitis : aspects on inflammation and malignancy
von Seth, E. (2018) · Figshare
Studies of innate and adaptive lymphocytes in human liver diseases and viral infections
Zimmer, C. L. (2019) · Figshare
Mabire, M., Gilgenkrantz, H., & Lotersztajn, S. (2023) · médecine/sciences · doi:10.1051/medsci/2023087
Zhang, L., Xu, J., You, X., Huang, S., Xue, F., Mou, T., Wu, Z., Wang, A., Hu, Y., Qu, Q., et al. (2024) · Research Square · doi:10.21203/rs.3.rs-3964596/v1
Wu, X., Chen, S., Yang, Y., Xu, X., Xiong, X., & Meng, W. (2024) · Research Square · doi:10.21203/rs.3.rs-4109315/v1
Gomes, W. R. (2024) · Digital Library of Theses and Dissertations (Universidade de São Paulo) · doi:10.11606/t.17.2024.tde-25072024-153611
Zhang, Y., Fan, Y., He, W., Han, Y., Bao, H., Yang, R., Wang, B., Kong, D., & Wang, H. (2021) · Figshare · doi:10.6084/m9.figshare.15071399
Zhang, Y., Fan, Y., He, W., Han, Y., Bao, H., Yang, R., Wang, B., Kong, D., & Wang, H. (2021) · Figshare · doi:10.6084/m9.figshare.15071402
Zhang, Y., Fan, Y., He, W., Han, Y., Bao, H., Yang, R., Wang, B., Kong, D., & Wang, H. (2021) · Figshare · doi:10.6084/m9.figshare.15071396
Innate-like T Cell Biology in the Tumor Microenvironment Implications for Cancer Immunotherapy
Pour, M. S., Nasimian, A., & Kazi, J. U. (2026) · Cells · doi:10.3390/cells15050402
Les cellules MAIT dans le diabète de type 1 chez l'homme
Nel, I. (2019) · theses.fr (ABES) · doi:10.70675/8eaa5bd8z1217z4729z8c2ezb385e0dbc1a9
IL - 17 et réponse inflammatoire systémique : focus sur le foie et le muscle
Beringer, A. (2018) · theses.fr (ABES) · doi:10.70675/2d9a348ez5879z4d92z938fz1e4047d398bc
Talvard-Balland, N. (2020) · theses.fr (ABES) · doi:10.70675/c97ca95bz9e5az4b51z9511zb52baa5010a2
Influence of bile acids metabolism on hepatic immunity in mice
Guinot, V. (2022) · theses.fr (ABES) · doi:10.70675/b69bb11eza30fz4874z9af2za6e31b2d5ad8
Intrahepatic T cell analysis reveals Th17 and MAIT17 enrichment in primary sclerosing cholangitis
Brynjulfsen, L. R. V., ElAbd, H., Øgaard, J., Jördens, M. S., Bozward, A. G., Kearns, D., Jiang, X., Folseraas, T., Trivedi, P. J., Oo, Y. H., et al. (2026) · JHEP Reports · doi:10.1016/j.jhepr.2026.101857
The biliary tree: A new frontier in mucosal immunology?
Guo, Y., Chouik, Y., Hao, Y., Kohlhepp, M. S., & Guillot, A. (2026) · Mucosal Immunology · doi:10.1016/j.mucimm.2026.04.006
Can we cure primary biliary cholangitis?
Trivedi, P. J., Hirschfield, G. M., & Gershwin, M. E. (2026) · Current Opinion in Immunology · doi:10.1016/j.coi.2026.102786
Kasprowicz‐Furmańczyk, M., & Owczarczyk-Saczonek, A. B. (2026) · Frontiers in Immunology · doi:10.3389/fimmu.2026.1886594
Xiong, J., Zhang, Z., Zhang, Z., Yuan, M., Zhu, K., Wang, F., & Shi, L. (2026) · eGastroenterology · doi:10.1136/egastro-2026-100526
Mucosal‐Associated Invariant T Cells in Health and Disease
Zhao, Y., Ou, F., Liang, D., Gao, Y., Li, Q., & Kuang, Y. (2026) · MedComm · doi:10.1002/mco2.70996
Regulatory T cells in autoimmune liver diseases
Chen, S., Zhang, H., Huang, H., Tsung, A., & Wang, H. (2026) · Gut · doi:10.1136/gutjnl-2026-338812
Metadata
- Authors
- Böttcher, K., Rombouts, K., Saffioti, F., Roccarina, D., Rosselli, M., Hall, A., Luong, T., Tsochatzis, E. A., Thorburn, D., & Pinzani, M.
- Affiliations
- The Royal Free Hospital (GB)
- University of Messina (IT)
- Corresponding author
- Böttcher, Katrin
- ORCID
- Venue
- Hepatology
- Published
- 2018-07
- Volume
- 68
- Issue
- 1
- Pages
- 172-186
- ISSN
- 0270-9139 (ISSN-L)
- OpenAlex
- W2783230342
- Cited by
- 183
- References
- 50
- Citations by year
- 2026: 12 · 2025: 17 · 2024: 24 · 2023: 24 · 2022: 20 · 2021: 26 · 2020: 35 · 2019: 16 · 2018: 8
- FWCI
- 13.32
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Licence
- Locations
- Hepatology (publishedVersion)
- PubMed (publishedVersion)
- UCL Discovery (University College London) (submittedVersion)
- Funders
- National Institute for Health and Care Research
- University College London Hospitals NHS Foundation Trust
- European Association for the Study of the Liver
- Innovate UK
- Royal Free Charity
- Topics
- Health Sciences › Medicine › Hepatology › Liver Diseases and Immunity
- Health Sciences › Medicine › Hepatology › Liver physiology and pathology
- Life Sciences › Pharmacology, Toxicology and Pharmaceutics › Pharmacology › Drug-Induced Hepatotoxicity and Protection
- Keywords
- mucosal-associated invariant T cells, autoimmune liver disease, liver fibrosis, hepatic stellate cell activation, T cell exhaustion, interferon-gamma, IL-12, IL-18, IL-17A, antifibrotic therapy, chronic liver disease
- MeSH terms
- Mucosal-Associated Invariant T Cells, Adult, Aged, Aged, 80 and over, Autoimmune Diseases, Female, Humans, Interleukins, Liver Cirrhosis, Lymphocyte Activation, Male, Middle Aged, Phenotype, Case-Control Studies, Cell Death, Hepatic Stellate Cells, Young Adult
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
